Infographic on Biosimilars
Health Canada has published a new biosimilar infographic on its website. This resource provides basic and concise information on biosimilars for patients.
Menu
Menu
Biosimilars news
Biosimilars Canada has compiled a list of news stories from Canada and abroad about biosimilars that may be of interest to readers. These links to third-party websites are provided for informational purposes only, and do represent an endorsement from our organization. Biosimilars Canada’s statements and news releases are available here.
Biosimilars: Integrated into the health care continuum
Only one year after the official coming into force of the biosimilar transition, they have already had a major impact on the Quebec health care system. They have enabled thousands of patients to be treated safely, while generating $140 million in savings that have been reinvested in patient care.
Ontario can save $155 million annually with switch to biosimilars
In this CFRB Newstalk 1010 interview Biosimilars Canada President Jim Keon discusses how Ontario can save money and support pharmaceutical investment through the implementation of a biosimilars switching policy.
Nova Scotia becomes sixth jurisdiction to implement biosimilar switching
As the Generics Bulletin reports, half of Canada’s provinces have now announced biosimilar switching policies.